We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$33.1B
AUM Growth
+$4.67B
Cap. Flow
+$3.45B
Cap. Flow %
10.43%
Top 10 Hldgs %
27.18%
Holding
755
New
214
Increased
168
Reduced
159
Closed
177

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$966M
2
AAPL icon
Apple
AAPL
+$767M
3
AMZN icon
Amazon
AMZN
+$706M
4
CRM icon
Salesforce
CRM
+$465M
5
NVDA icon
NVIDIA
NVDA
+$401M

Sector Composition

Rank Sector Weight
1 Technology 23.68%
2 Consumer Discretionary 13.65%
3 Industrials 9.63%
4 Healthcare 8.71%
5 Real Estate 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLB icon
426
Columbia Banking Systems
COLB
$8.84B
$6.63M 0.02%
+257,726
New +$6.55M
KSS icon
427
Kohl's
KSS
$2.16B
$6.62M 0.02%
430,744
-2,751,450
-86% -$36.7M
PM icon
428
Philip Morris
PM
$290B
$6.6M 0.02%
40,664
-1,472
-3% -$248K
XYZ
429
Block Inc
XYZ
$47.5B
$6.32M 0.02%
87,507
-40,479
-32% -$3.03M
CCCX
430
DELISTED
Churchill Capital Corp X
CCCX
$6.31M 0.02%
+490,989
New +$5.19M
VC icon
431
Visteon
VC
$2.8B
$6.29M 0.02%
52,504
+43,460
+481% +$5.11M
BNC
432
CEA Industries
BNC
$99.2M
$6.22M 0.02%
+797,035
New +$13.5M
NE icon
433
Noble Corp
NE
$6.95B
$6.13M 0.02%
216,628
-203,730
-48% -$5.77M
LRMR icon
434
Larimar Therapeutics
LRMR
$417M
$6.1M 0.02%
1,887,169
-188,713
-9% -$708K
CMCSA icon
435
Comcast
CMCSA
$89.4B
$6.09M 0.02%
+193,820
New +$6.5M
BV icon
436
BrightView Holdings
BV
$1.05B
$6.03M 0.02%
450,000
+25,000
+6% +$371K
OS
437
DELISTED
OneStream Inc
OS
$6M 0.02%
325,539
-474,461
-59% -$10.4M
TWFG
438
TWFG Inc
TWFG
$359M
$5.92M 0.02%
215,778
+4,192
+2% +$121K
CVLT icon
439
Commault Systems
CVLT
$5.78B
$5.89M 0.02%
+31,216
New +$5.63M
AGIO icon
440
Agios Pharmaceuticals
AGIO
$1.95B
$5.88M 0.02%
+146,514
New +$5.51M
CRGY icon
441
Crescent Energy
CRGY
$4.03B
$5.72M 0.02%
640,957
-1,026,923
-62% -$9.33M
BNTX icon
442
BioNTech
BNTX
$23.3B
$5.69M 0.02%
+57,668
New +$6.17M
SI
443
Shoulder Innovations Inc
SI
$432M
$5.67M 0.02%
+451,536
New +$6.31M
AUGO
444
Aura Minerals Inc
AUGO
$6.37B
$5.58M 0.02%
+150,000
New +$4.31M
JBL icon
445
Jabil
JBL
$35.3B
$5.53M 0.02%
+25,483
New +$5.55M
HAS icon
446
Hasbro
HAS
$13.3B
$5.53M 0.02%
+72,848
New +$5.65M
SION
447
Sionna Therapeutics
SION
$203M
$5.48M 0.02%
186,222
GRDN
448
Guardian Pharmacy Services
GRDN
$2.63B
$5.44M 0.02%
207,393
-571,177
-73% -$13.6M
CPRX
449
DELISTED
Catalyst Pharmaceutical
CPRX
$5.38M 0.02%
+273,287
New +$5.62M
BEAGU
450
Bold Eagle Acquisition Corp Units
BEAGU
$5.35M 0.02%
499,990

Similar funds

Alyeska Investment Group's Q3 2025 Portfolio in Review

As of Q3 2025, Alyeska Investment Group held 755 positions worth $33.1B, up 16% from $28.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Alyeska Investment Group deployed $3.45B of net new capital in Q3 2025, opening 214 new positions and adding to 168 existing holdings. Its largest new stake was Tesla: 804,280 shares worth $358M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $379M trimmed.

  • Alyeska Investment Group's largest Q3 2025 buy was Tesla: 804,280 shares worth $358M.
  • Alyeska Investment Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $966M increase.
  • Alyeska Investment Group's biggest Q3 2025 reduction was JPMorgan Chase, cutting an estimated $379M.
  • Alyeska Investment Group fully exited Wayfair in Q3 2025, selling an estimated $298M.
  • Alyeska Investment Group's ten largest holdings make up 27% of its $33.1B portfolio in Q3 2025.
  • Alyeska Investment Group opened 214 new positions and closed 177 in Q3 2025.
  • Alyeska Investment Group's portfolio value rose 16% quarter-over-quarter to $33.1B.

Based on Alyeska Investment Group's 13F filing for Q3 2025, filed 17 Nov 2025.